Staying Up to Date with COVID-19 Vaccines | Covid | CDC
Nov 19, 2025 · People who are up to date with their COVID-19 vaccine have lower risk of severe illness.
2025–2026 COVID-19 Vaccination Guidance | Covid | CDC
Nov 4, 2025 · The 2025–2026 COVID-19 vaccine is recommended for people ages 6 months and older based on individual-based decision-making (also known as shared clinical decision …
CDC developed the Booster Seat Planning Guide to assist States, Tribes, Localities, and Territories (STLTs) with assessing, planning, and implementing improved booster seat laws to …
ACIP Update to the Evidence to Recommendations for a 2nd …
Sep 5, 2024 · As the 2nd booster is already authorized and available, recommendations can rapidly adjust if COVID-19 epidemiology changes in the future. The current recommendation …
CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine …
October 23, 2024 - Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for people 65 years and older and those …
Booster Seat Planning Guide | Child Passenger Safety | CDC
Aug 14, 2025 · CDC's Booster Seat Planning Guide can assist states, tribes, localities, and territories with assessing, planning, and implementing improved booster seat laws to reduce …
Getting Your COVID-19 Vaccine | Covid | CDC
Jun 10, 2025 · Learn how to schedule an appointment to get your COVID-19 vaccine and know what to expect at your appointment.
ACIP Update to the Evidence to Recommendations for a Pfizer …
Sep 5, 2024 · Overall, the Work Group supported the current recommendation that children ages 5-11 years may receive a COVID-19 vaccine booster dose with the flexibility to adjust to a …
Meningococcal Vaccine Recommendations | Meningococcal | CDC
Jul 1, 2025 · Since protection wanes, CDC recommends a MenACWY booster dose at age 16 years. The booster dose provides protection during the ages when adolescents are at highest …
Measles Vaccine Recommendations | Measles (Rubeola) | CDC
Sep 20, 2024 · Find routine MMR information, evidence of immunity, other considerations for measles vaccine.